Related references
Note: Only part of the references are listed.Tumor mutational load, CD8+ T cells, expression of PD-L1 and HLA class I to guide immunotherapy decisions in NSCLC patients
Daan P. Hurkmans et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Granzyme B is correlated with clinical outcome after PD-1 blockade in patients with stage IV non-small-cell lung cancer
Daan P. Hurkmans et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Granzyme B Degraded Type IV Collagen Products in Serum Identify Melanoma Patients Responding to Immune Checkpoint Blockade
Christina Jensen et al.
CANCERS (2020)
Anti-PD-L1 Treatment Results in Functional Remodeling of the Macrophage Compartment
Huizhong Xiong et al.
CANCER RESEARCH (2019)
Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology
Neel I. Nissen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Deep Mining of Complex Antibody Phage Pools Generated by Cell Panning Enables Discovery of Rare Antibodies Binding New Targets and Epitopes
Anne Ljungars et al.
FRONTIERS IN PHARMACOLOGY (2019)
Collagen fragments quantified in serum as measures of desmoplasia associate with survival outcome in patients with advanced pancreatic cancer
Nicholas Willumsen et al.
SCIENTIFIC REPORTS (2019)
Why target the tumor stroma in melanoma?
James Hutchenreuther et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2018)
Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers
Muhammad Umair Mushtaq et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Predictive and on-treatment monitoring biomarkers in advanced melanoma: Moving toward personalized medicine
Ahmad Tarhini et al.
CANCER TREATMENT REVIEWS (2018)
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan et al.
NATURE (2018)
TGF-β-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure
Ankur Chakravarthy et al.
NATURE COMMUNICATIONS (2018)
Non-invasive biomarkers derived from the extracellular matrix associate with response to immune checkpoint blockade (anti-CTLA-4) in metastatic melanoma patients
Christina Jensen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Transcriptomic analysis of hepatocellular carcinoma reveals molecular features of disease progression and tumor immune biology
K. Okrah et al.
NPJ PRECISION ONCOLOGY (2018)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
Sydney R. Gordon et al.
NATURE (2017)
Melanoma-associated fibroblasts decrease tumor cell susceptibility to NK cell-mediated killing through matrix-metalloproteinases secretion
Linda Ziani et al.
ONCOTARGET (2017)
Biomarkers for Response of Melanoma Patients to Immune Checkpoint Inhibitors: a Systematic Review
Charissa A. C. Jessurun et al.
FRONTIERS IN ONCOLOGY (2017)
Progress and opportunities for enhancing the delivery and efficacy of checkpoint inhibitors for cancer immunotherapy
David M. Francis et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
Jeffrey E. Gershenwald et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade
Spencer C. Wei et al.
CELL (2017)
Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab
Benjamin Weide et al.
CLINICAL CANCER RESEARCH (2016)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
Perforin and granzymes: function, dysfunction and human pathology
Ilia Voskoboinik et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Granzyme B Promotes Cytotoxic Lymphocyte Transmigration via Basement Membrane Remodeling
Monica D. Prakash et al.
IMMUNITY (2014)
Post-translational modifications of the extracellular matrix are key events in cancer progression: Opportunities for biochemical marker development
D. J. Leeming et al.
BIOMARKERS (2011)
Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer
Thomas R. Cox et al.
DISEASE MODELS & MECHANISMS (2011)
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kai Kessenbrock et al.
CELL (2010)
Novel combinations of Post-Translational Modification (PTM) neo-epitopes provide tissue-specific biochemical markers-are they the cause or the consequence of the disease?
Morten Asser Karsdal et al.
CLINICAL BIOCHEMISTRY (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
TGF-β1 attenuates the acquisition and expression of effector function by tumor antigen-specific human memory CD8 T cells
M Ahmadzadeh et al.
JOURNAL OF IMMUNOLOGY (2005)
Share Paper
